Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects-Reference-Cited by-同舟云学术

Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects

Published:2023-06 Issue:2 Volume:17 Page:180-188
ISSN:1819-7124
Container-title:Neurochemical Journal
language:en
Short-container-title:Neurochem. J.

Author:

Voronina T. A.

Abstract

Abstract—This review provides information about the features of cognitive dysfunctions that occur in various diseases and conditions, and data on the history of the creation and characteristic features of nootropics. The review presents the mechanisms of action and the spectrum of pharmacological effects of nootropic drugs from various groups: drugs that affect brain metabolism, neurotransmitter systems (cholinergic, glutamatergic, GABAergic, and others), cerebral vasodilators, neuropeptides and their analogues, antioxidants, membrane protectors, and others. The free radical and mitochondrial concepts of aging and the possibility of using nootropics for the correction of cognitive impairments arising from aging, dementia, and other neurodegenerative diseases are considered.

Publisher

Pleiades Publishing Ltd

Subject

Cellular and Molecular Neuroscience,Molecular Biology,Biochemistry

Link

https://link.springer.com/content/pdf/10.1134/S1819712423020198.pdf

Reference136 articles.

1. Zakharov, V.V. and Yakhno, N.N., Narusheniya pamyati (Disturbances of Memory), M.: GeotarMed, 2003, p. 150.

2. Damulin, I.V., Bolezn’ Al’tsgeimera i sosudistaya dementsiya (Alzheimer’s Disease and Vascular Dementia), M.: Nauka, 2002, p. 85.

3. Taylor, K., The Fragile Brain: The Strange, Hopeful Science of Dementia, New York: Oxford University Press, 2017.

4. Moustafa, A.A., Alzheimer’s Disease, New York: Academic Press, 2021.

5. Yakhno, N.N., Dostizheniya v neirogeriatrii (Achievements of Neurogeriatrics), Yakhno, N.N. and Damulin, I.V., Eds., Moscow: Izd. MMA, 1995, pp. 9–29